HBM Holdings (SEHK:2142) Valuation Check After Recent Share Price Rebound

Simply Wall St.03-11

AdvertisementRecent performance snapshot for HBM Holdings HBM Holdings (SEHK:2142) has been on the radar after recent price moves, with the stock showing a mix of gains over the past month and past 3 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2618962570?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-03-11 02:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618962570","market":"sg","top_or_hot":-1,"title":"HBM Holdings (SEHK:2142) Valuation Check After Recent Share Price Rebound","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementRecent performance snapshot for HBM Holdings HBM Holdings (SEHK:2142) has been on the radar after recent price moves, with the stock showing a mix of gains over the past month and past 3 ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-valuation-check-after-recent-share-pri\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HBM Holdings (SEHK:2142) Valuation Check After Recent Share Price Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHBM Holdings (SEHK:2142) Valuation Check After Recent Share Price Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-11 02:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-valuation-check-after-recent-share-pri><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementRecent performance snapshot for HBM Holdings HBM Holdings (SEHK:2142) has been on the radar after recent price moves, with the stock showing a mix of gains over the past month and past 3 ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-valuation-check-after-recent-share-pri\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02142","symbol_name":"和铂医药-B","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-valuation-check-after-recent-share-pri","article_id":"2618962570","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-valuation-check-after-recent-share-pri","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2618962570","pubTimestamp":1773167020,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Recent performance snapshot for HBM Holdings\nHBM Holdings (SEHK:2142) has been on the radar after recent price moves, with the stock showing a mix of gains over the past month and past 3 months alongside longer term total return figures.\nSee our latest analysis for HBM Holdings.\nThe recent 1 day share price return of 6.34% and 7 day return of 7.37% at a HK$12.24 share price sit against a 30 day share price return of 10.97%, a 90 day share price decline of 11.50% and a very large 3 year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"02142":"和铂医药-B","BK1161":"生物科技","HBM":"HudBay Minerals Inc","BK4168":"多种金属与采矿","BK1574":"生物医药B类股","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK1583":"高瓴概念"},"translate_title":"HBM Holdings(SEHK：2142)近期股价反弹后的估值检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HBM":0.9,"02142":0.9,"DCF":1},"content_text":"AdvertisementRecent performance snapshot for HBM Holdings HBM Holdings (SEHK:2142) has been on the radar after recent price moves, with the stock showing a mix of gains over the past month and past 3 months alongside longer term total return figures. See our latest analysis for HBM Holdings. The recent 1 day share price return of 6.34% and 7 day return of 7.37% at a HK$12.24 share price sit against a 30 day share price return of 10.97%, a 90 day share price decline of 11.50% and a very large 3 year total shareholder return of 485.65%. This suggests momentum has picked up again after a weaker spell. If this kind of rebound has you thinking about what else is moving, it could be a good time to widen the lens and check out 117 healthcare AI stocks as a fresh set of ideas. With HBM Holdings posting a very large 3 year total return yet trading about 47% below the HK$18.01 average analyst price target, the key question is whether there is still an opportunity here or if the market is already pricing in future growth. Price-to-Earnings of 17.9x: Is it justified? Based on the latest data, HBM Holdings trades on a P/E of 17.9x, which sits below both the Asian Biotechs average of 38.5x and the broader Biotechs industry average of 48.9x, yet is slightly above the estimated fair P/E of 17.6x. The P/E ratio compares the company’s share price to its earnings per share and is a common way investors think about what they are paying for each unit of current earnings. For a profitable biopharmaceutical business like HBM Holdings, it gives a quick read on how the market is valuing its earnings stream today. Here, HBM Holdings is described as good value versus both its peer group average of 77.4x and the wider industry. This suggests the market is pricing its earnings below many comparable biotech names. At the same time, the P/E is flagged as slightly expensive relative to an estimated fair P/E of 17.6x. This is a level the market could potentially gravitate toward if sentiment or earnings expectations shift. Explore the SWS fair ratio for HBM Holdings Result: Price-to-earnings of 17.9x (ABOUT RIGHT) However, you will want to weigh execution risks in the drug pipeline and any shift in sentiment if current revenue or net income growth rates of 7% and 3% change. Find out about the key risks to this HBM Holdings narrative. Another view: cash flows tell a different story While the P/E of 17.9x makes HBM Holdings look cheaper than many biotech peers, our DCF model points the other way. With the shares at HK$12.24 versus an estimated cash flow value of HK$9.39, the model suggests the stock is trading at a premium. So which signal matters more to you: earnings or cash flows? Look into how the SWS DCF model arrives at its fair value. 2142 Discounted Cash Flow as at Mar 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out HBM Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 228 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps Does this mix of signals feel balanced or conflicted to you? Take a moment to look through the numbers yourself, then move quickly to shape your own view by weighing 3 key rewards and 2 important warning signs. Looking for more investment ideas? If this has sharpened your thinking on HBM Holdings, do not stop here; use the same tools to line up your next few ideas with confidence.  Target resilient balance sheets and fundamentals by scanning our solid balance sheet and fundamentals stocks screener (373 results) that highlight companies with financial strength front and center. Hunt for potential value opportunities with our 228 high quality undervalued stocks that surface companies combining quality fundamentals with prices that may not fully reflect them. Stack your watchlist with potential income ideas using the 460 dividend fortresses that focuses on higher yielding companies with an emphasis on stability.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if HBM Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618962570","isCrawlerRequest":true}